The CCL5/CCR1/β-catenin/Slug pathway is responsible for the tumor-promoting effect of TNF-α-activated hMSCs on colon cancer development. Strategies targeting MSCS-cancer cell crosstalk should provide a new approach to cancer therapy. This evidence concerns the gene SNAI2 and colonic neoplasm.